CRYBA1
Beta-crystallin A3
Also known as: CRBA1_HUMAN, CRYB1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P05813
- Gene
- CRYBA1
- Ensembl
- ENSG00000108255
- Chromosome
- 17
- Canonical length
- 215 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta acidic group member, encodes two proteins (crystallin, beta A3 and crystallin, beta A1) from a single mRNA, the latter protein is 17 aa shorter than crystallin, beta A3 and is generated by use of an alternate translation initiation site. Deletion of exons 3 and 4 causes the autosomal dominant disease 'zonular cataract with sutural opacities'. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
215 residues, UniProt reviewed canonical sequence.
>P05813|CRYBA1
1 METQAEQQEL ETLPTTKMAQ TNPTPGSLGP WKITIYDQEN FQGKRMEFTS SCPNVSERSF
61 DNVRSLKVES GAWIGYEHTS FCGQQFILER GEYPRWDAWS GSNAYHIERL MSFRPICSAN
121 HKESKMTIFE KENFIGRQWE ISDDYPSLQA MGWFNNEVGS MKIQSGAWVC YQYPGYRGYQ
181 YILECDHHGG DYKHWREWGS HAQTSQIQSI RRIQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRYBA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- retina: 0.2 nTPM
- appendix: 0.1 nTPM
- bone marrow: 0.1 nTPM
- spinal cord: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- cardiomyocytes: 13 nCPM
- epicardial cells: 9.1 nCPM
- schwann cells: 6.3 nCPM
- syncytiotrophoblasts: 6.3 nCPM
- thymocytes: 5.1 nCPM
- myonuclei: 3.8 nCPM
Immune cell
- intermediate monocyte: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- white matter: 6.9 nTPM
- cerebellum: 5.7 nTPM
- pons: 4.8 nTPM
- thalamus: 4.6 nTPM
- medulla oblongata: 4.5 nTPM
- basal ganglia: 4.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CRYBA1.
Disease | AllUniProt
Conditions CRYBA1 is implicated in, by any mechanism.
- Cataract 10, multiple types (CTRCT10) MIM:600881
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 94 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cataract 10 multiple types
- CRYBA1-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- -0.18
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lens development in camera-type eye
- negative regulation of cytokine production
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of TOR signaling
- phagocytosis
- positive regulation of anoikis
- regulation of autophagy
- visual perception
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CRYBA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRYBA1 as an antibody target. Whether an autoantibody or antibody against CRYBA1 could matter depends on whether native CRYBA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRYBA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRYBA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...